Committees and groups

The Better Access Evaluation – Clinical Advisory Group (CAG) has been established to give input, advice and feedback on the evaluation of the Better Access initiative.

The Health Services Data Advisory Group (HS DAG) advises us on Aboriginal and Torres Strait Islander health data. It also contributes to the development and continuous improvement of the Health Data Portal, which collects key data.

The Advisory Committee for the COVID-19 Response for People with Disability provides advice to the Chief Medical Officer about the needs of people with disability during the COVID-19 pandemic.

The Advisory Committee on Vaccines (ACV) provides independent medical and scientific advice to the Minister for Health and the Therapeutic Goods Administration (TGA).

The Aged Care Advisory Group advises the Australian Health Protection Principal Committee about aged care policy related to infectious diseases and emergency preparedness. It brings together expertise about the aged care sector, infection control, emergency preparedness and public health response.

Older people have a formal voice to Government on ageing and aged care through the members of the Aged Care Council of Elders.

ACFA operated from 2012 following the Living Longer Living Better reforms to aged care until 30 June 2021. It provided independent advice about aged care funding and financing to the Australian Government, including the provision of an annual report on the funding of the aged care industry.

Users will be able to view the membership, purpose, and activities of the Allied Health Industry Reference Group (AHIRG). A summary of each meeting, and each meeting’s communique, will be available from this page, along with contact details for public enquiries.

The Australian Brain Cancer Mission Strategic Advisory Group (Strategic Advisory Group) advises the government on the research priorities for this Medical Research Future Fund (MRFF) Mission.

The ACPA is an independent statutory body that considers applications for approval to supply pharmaceutical benefits and recommends whether they should be approved.

The Australian Health Protection Principal Committee is the key decision-making committee for health emergencies. Australia's Chief Medical Officer chairs this committee, which includes all state and territory Chief Health Officers.

The Australian Medical Research Advisory Board (AMRAB) advises the Minister for Health and Aged Care on prioritising spending from the Medical Research Future Fund (MRFF).

ANACAD advises the Australian Government on issues related to alcohol and other drugs.

The Australian Technical Advisory Group on Immunisation (ATAGI) advises the Minister for Health and Aged Care on the National Immunisation Program (NIP) and other immunisation issues.

The Better Access Evaluation – Stakeholder engagement group (SEG) has been established to consult on the evaluation of the Better Access initiative.

The Bilateral Regional Health Forum supports the health needs of people in rural, regional and remote New South Wales. The forum discusses rural health issues and ensures a collaborative approach to regional health outcomes.

The BBVSS provides strategic advice to the Health Chief Executives Forum as part of a coordinated response to bloodborne viruses (BBV) and sexually transmissible infections (STI) across Australia.

The BreastScreen Australia Clinical Advisory Committee (CAC) provides expert advice to BreastScreen Australia Program managers about clinical issues.

The Cardiovascular Health Mission Expert Advisory Panel advises the government on the research priorities for this Medical Research Future Fund (MRFF) mission.

These groups assess the clinical functionality and effectiveness of products being considered for listing on the Prostheses List.

The Clinical Categories Review Advisory Committee (CCRAC) will support the Clinical Categories Review.

The CIRG is an independent group of clinicians who provide advice to the Australian Government on measures being implemented as part of the Prostheses List reforms.

The CDNA provides national public health coordination and leadership, particularly around disease surveillance. It supports best practice for the prevention and control of communicable diseases.

The aim of the CPCC is to support achievement of the objectives of the Seventh Community Pharmacy Agreement (7CPA). It is one of the two committees that facilitate consultation on the 7CPA.

The Comprehensive Primary Health Care Sustainability Advisory Committee monitors the Indigenous Australians’ Health Programme funding model. The committee then advises us on how it is performing and how we can continue to improve it.